Advanced mechanical design to address both subacute, organized thrombus and more dense, fibrotic tissue; devices with a low ...

Bilateral simultaneous central retinal artery occlusion (CRAO) in a patient with systemic lupus erythematosus (SLE). Am J Ophthalmol Case Rep. 2020;19:100833. Stähli BE, Camici GG, Steffel J, et al.

Regeneron seeks FDA approval for EYLEA HD, a novel treatment for retinal vein occlusion, offering less frequent dosing.

The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

Most patients in the United States who present to hospital emergency departments with acute central retinal artery occlusion do not undergo stroke workup imaging.

Aims To investigate the associations between a healthy lifestyle score and retinal neurovascular health, and explore whether lower inflammation levels mediate these associations. Methods This study is ...

Aims Previous studies have suggested an association between retinal artery occlusion (RAO) and ischaemic stroke (IS), both associated with elevated inflammatory factors. However, the role of ...

Regeneron Announces Positive Phase 3 Results For EYLEA HD In Retinal Vein Occlusion Treatment February 08, 2025 — 11:36 pm EST Written by RTTNews.com for RTTNews -> ...

Central retinal artery occlusion (CRAO) is a rare subtype of acute ischemic stroke resulting in devastating visual loss. Limited studies on intravenous tissue plasminogen activator (tPA) showed some ...

An occlusion of the inferior arterial hemi-trunk of the central retinal artery was apparent and fluorescein angiography showed a hemi-central retinal artery occlusion in the right eye (C) and multiple ...